Yantai Zhenghai Biotechnology Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kan Song

Algemeen directeur

CN¥1.1m

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	1.9yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	4.6yrs
Gemiddelde ambtstermijn bestuur	5.2yrs

Recente managementupdates

Recent updates

CEO

Kan Song (41 yo)

1.9yrs

Tenure

CN¥1,116,100

Compensatie

Mr. Kan Song is Chairman since April 12, 2023 & General Manager and Director of Yantai Zhenghai Biotechnology Co., Ltd. from January 06, 2023. He is Secretary of Yantai Zhenghai Biotechnology Co., Ltd sinc...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kan Song	GM, Secretary & Chairman	1.9yrs	CN¥1.12m	geen gegevens
Li Zhao	Deputy GM	no data	CN¥904.90k	geen gegevens
Xing Yang	Deputy General Manager	4.6yrs	CN¥1.52m	geen gegevens
Donggang Zhang	Deputy General Manager	7.3yrs	CN¥907.90k	geen gegevens

4.6yrs

Gemiddelde duur

46.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 300653 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kan Song	GM, Secretary & Chairman	1.8yrs	CN¥1.12m	geen gegevens
Li Zhao	Deputy GM	4.5yrs	CN¥904.90k	geen gegevens
Dong Qun	Vice Chairman	9.4yrs	geen gegevens	geen gegevens
Chao Zhang	Non-Independent Director	6.6yrs	geen gegevens	geen gegevens
Weiguo Jiang	Non-Independent Director	5.2yrs	geen gegevens	geen gegevens
Hui Xu	Independent Director	3.6yrs	CN¥60.00k	geen gegevens
Xiliang Song	Independent Director	3.6yrs	CN¥60.00k	geen gegevens
Landing Zhang	Independent Director	3.6yrs	CN¥60.00k	geen gegevens
Yueli Xu	Chairman of the Supervisory Board	9.4yrs	geen gegevens	geen gegevens
Lishan Pan	Non-Employee Supervisor	5.2yrs	geen gegevens	geen gegevens
Lei Zhao	Employee Supervisor	9.4yrs	geen gegevens	geen gegevens

5.2yrs

Gemiddelde duur

49yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 300653 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.2 jaar).

Yantai Zhenghai Biotechnology Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

Yantai Zhenghai Biotechnology Co., Ltd., Annual General Meeting, Apr 22, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

Third quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.21 in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

New major risk - Share price stability

Yantai Zhenghai Biotechnology Co., Ltd. to Report Q3, 2024 Results on Oct 23, 2024

Investor sentiment improves as stock rises 16%

Now 22% overvalued

Now 20% overvalued

Investor sentiment deteriorates as stock falls 17%

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: CN¥0.26 (vs CN¥0.31 in 2Q 2023)

Yantai Zhenghai Biotechnology Co., Ltd. to Report First Half, 2024 Results on Aug 06, 2024

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Dividend on A Shares for the Year 2023, Payable on 14 June 2024

Investor sentiment improves as stock rises 17%

First quarter 2024 earnings released: EPS: CN¥0.22 (vs CN¥0.30 in 1Q 2023)

Yantai Zhenghai Biotechnology Co., Ltd., Annual General Meeting, Apr 22, 2024

Full year 2023 earnings released: EPS: CN¥1.06 (vs CN¥1.28 in FY 2022)

Yantai Zhenghai Biotechnology Co., Ltd. to Report Q1, 2024 Results on Apr 29, 2024

Investor sentiment deteriorates as stock falls 15%

Yantai Zhenghai Biotechnology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 02, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.28 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.31 (vs CN¥0.27 in 2Q 2022)

Yantai Zhenghai Biotechnology Co., Ltd. to Report First Half, 2023 Results on Aug 01, 2023

Yantai Zhenghai Biotechnology Co., Ltd. Implements Final Cash Dividend of 10 A Shares for 2022, Payable on May 30, 2023

Now 29% undervalued after recent price drop

Full year 2022 earnings released: EPS: CN¥1.28 (vs CN¥0.93 in FY 2021)

Full year 2022 earnings released: EPS: CN¥1.01 (vs CN¥0.93 in FY 2021)

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.28 (vs CN¥0.25 in 3Q 2021)

Investor sentiment improved over the past week

Now 26% undervalued after recent price drop

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS: CN¥0.27 (vs CN¥0.21 in 2Q 2021)

Investor sentiment improved over the past week

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2021, Payable on May 19, 2022

High number of new and inexperienced directors

First quarter 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.37 in 1Q 2021)

Yantai Zhenghai Biotechnology Co., Ltd. Proposes Distribution for 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.37 (vs CN¥0.34 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.31 (vs CN¥0.30 in 2Q 2020)

Yantai Zhenghai Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2020, Payable on May 20, 2021

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.37 (vs CN¥0.16 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.99 (vs CN¥0.89 in FY 2019)

New 90-day low: CN¥45.02

New 90-day low: CN¥49.35

New 90-day low: CN¥52.20

New 90-day low: CN¥57.91

New 90-day low: CN¥61.00

Third quarter earnings released

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd